دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
The risk of ‘hidden’ sodium and of low vitamin D levels
Filippo Crea
doi : 10.1093/eurheartj/ehac203
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1687–1690
The Atrial Fibrillation Heart Team—guiding therapy in left atrial appendage occlusion with increasingly complex patients and little evidence
Shinwan Kany, Andreas Metzner, Edith Lubos, Paulus Kirchhof
doi : 10.1093/eurheartj/ehab744
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1691–1692
In memoriam—Dr. Hikaru Sato: the discoverer of Takotsubo syndrome
Michiaki Nagai, Keigo Dote, Masaharu Ishihara, Satoshi Kurisu
doi : 10.1093/eurheartj/ehac146
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1693–1696
Heart failure: a 70 year Odyssey
Eugene Braunwald
doi : 10.1093/eurheartj/ehac058
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1697–1699
Unloading left heart with a shunt device shows no benefits in heart failure with preserved ejection fraction but supports the importance of phenotyping patients in clinical trials
Massimo Volpe, Giovanna Liuzzo
doi : 10.1093/eurheartj/ehac127
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1700–1701
A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study
Xiangfeng Lu, Zhongying Liu, Qingmei Cui, Fangchao Liu, Jianxin Li, Xiaoge Niu, Chong Shen, Dongsheng Hu, Keyong Huang, Jichun Chen, Xiaolong Xing, Yingxin Zhao, Fanghong Lu, Xiaoqing Liu, Jie Cao, Shufeng Chen, Hongxia Ma, Ling Yu, Xianping Wu, Xigui Wu, Ying Li, Huan Zhang, Xingbo Mo, Liancheng Zhao, Jianfeng Huang, Laiyuan Wang, Wanqing Wen, Xiao-Ou Shu, Fumihiko Takeuchi, Woon-Puay Koh, E Shyong Tai, Ching-Yu Cheng, Tien yin Wong, Xuling Chang, Mark Yan-Yee Chan, Wei Gao, Hong Zheng, Kexin Chen, Jing Chen, Jiang He, Clara Sze-man Tang, Karen Siu Ling Lam, Hung-fat Tse, Chloe Yu Yan Cheung, Atsushi Takahashi, Michiaki Kubo, Norihiro Kato, Chikashi Terao, Yoichiro Kamatani, Pak Chung Sham, Chew-Kiat Heng, Zhibin Hu, Y Eugene Chen, Tangchun Wu, Hongbing Shen, Cristen J Willer, Dongfeng Gu
doi : 10.1093/eurheartj/ehac093
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1702–1711
To construct a polygenic risk score (PRS) for coronary artery disease (CAD) and comprehensively evaluate its potential in clinical utility for primary prevention in Chinese populations.
Polygenic risk score: a tool ready for clinical use?
Maryam Kavousi, Heribert Schunkert
doi : 10.1093/eurheartj/ehab923
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1712–1714
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
Steven H J Hageman, Ailsa J McKay, Peter Ueda, Laura H Gunn, Tomas Jernberg, Emil Hagström, Deepak L Bhatt, Ph. Gabriel Steg, Kristi Läll, Reedik Mägi, Mari Nordbø Gynnild, Hanne Ellekjær, Ingvild Saltvedt, José Tuñón, Ignacio MahÃllo, Ã�lvaro Aceña, Karol Kaminski, Malgorzata Chlabicz, Emilia Sawicka, Taavi Tillman, John W McEvoy, Emanuele Di Angelantonio, Ian Graham, Dirk De Bacquer, Kausik K Ray, Jannick A N Dorresteijn, Frank L J Visseren
doi : 10.1093/eurheartj/ehac056
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1715–1727
The 10-year risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events in patients with established ASCVD can be estimated with the Secondary Manifestations of ARTerial disease (SMART) risk score, and may help refine clinical management. To broaden generalizability across regions, we updated the existing tool (SMART2 risk score) and recalibrated it with regional incidence rates and assessed its performance in external populations.
Risk scoring in secondary prevention: a basis for informed clinical decisions in the context of ever-expanding treatments
Naveed Sattar, Paul Welsh
doi : 10.1093/eurheartj/ehac125
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1728–1730
Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk
Ang Zhou, Joseph B Selvanayagam, Elina Hyppönen
doi : 10.1093/eurheartj/ehab809
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1731–1739
Low vitamin D status is associated with a higher risk for cardiovascular diseases (CVDs). Although most existing linear Mendelian randomization (MR) studies reported a null effect of vitamin D on CVD risk, a non-linear effect cannot be excluded. Our aim was to apply the non-linear MR design to investigate the association of serum 25-hydroxyvitamin D [25(OH)D] concentration with CVD risk.
Genetic evidence for vitamin D and cardiovascular disease: choice of variants is critical
Stephen Burgess, Dipender Gill
doi : 10.1093/eurheartj/ehab870
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1740–1742
Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension
Chao Zeng, Lynn Rosenberg, Xiaoxiao Li, Luc Djousse, Jie Wei, Guanghua Lei, Yuqing Zhang
doi : 10.1093/eurheartj/ehac059
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1743–1755
Previous studies have found high sodium intake to be associated with increased risks of cardiovascular disease (CVD) and all-cause mortality among individuals with hypertension; findings on the effect of intake among individuals without hypertension have been equivocal. We aimed to compare the risks of incident CVD and all-cause mortality among initiators of sodium-containing acetaminophen with the risk of initiators of non-sodium-containing formulations of the same drug according to the history of hypertension.
The sodium hidden in medication: a tough pill to swallow
Aletta E Schutte, Bruce Neal
doi : 10.1093/eurheartj/ehab888
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1756–1758
Sex-related differences in treatment and outcome of chronic limb-threatening ischaemia: a real-world cohort
Lena Makowski, Jeanette Köppe, Christiane Engelbertz, Leonie Kühnemund, Alicia J Fischer, Stefan A Lange, Patrik Dröge, Thomas Ruhnke, Christian Günster, Nasser Malyar, Joachim Gerß, Eva Freisinger, Holger Reinecke, Jannik Feld
doi : 10.1093/eurheartj/ehac016
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1759–1770
The prevalence of chronic limb-threatening ischaemia (CLTI) is increasing and available data often derive from cohorts with various selection criteria. In the present study, we included CLTI patients and studied sex-related differences in their risk profile, vascular procedures, and long-term outcome.
Sex equality or sex equity: what are we looking for in treating limb-threatening ischaemia?
David Kingsmore, Julie Brittenden
doi : 10.1093/eurheartj/ehac047
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1771–1773
Complete resolution of apical hypertrophy and fibrosis: the role of serial cardiovascular magnetic resonance tissue characterization to differentiate hypertrophic cardiomyopathy from myocarditis
James Wilson, Amal Muthumala, Mohammed Y Khanji
doi : 10.1093/eurheartj/ehac108
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Page 1774
Electrical alternans detected by an Apple Watch
Irene Carrión-Sánchez, Miguel �ngel Cobos-Gil
doi : 10.1093/eurheartj/ehab806
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Page 1775
Corrigendum to: Mild cognitive impairment in middle-aged adults with coronary microvascular dysfunction
A Nowroozpoor, E Sharp, R Gordon, C Malicki, U Hwang, J Dziura, G D’Onofrio’, B Safdar
doi : 10.1093/eurheartj/ehab845
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Page 1776
Corrigendum to: Fall in the ATP levels in the red blood cells in ApoE-LDLR double-deficient mice model prior to atherosclerosis development
F C Alcicek, T Mohaissen, K Bulat, E Szczesny-Malysiak, J Dybas, U Tyrankiewicz, M Kaczmarska, K M Marzec, S Chlopicki
doi : 10.1093/eurheartj/ehab848
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Page 1776
Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Page 1776
